FIGO stage IIIC endometrial carcinoma: prognostic factors and outcomes (Q37475835)

20 August 2017

title

FIGO stage IIIC endometrial carcinoma: prognostic factors and outcomes (English)

1 reference

20 August 2017

main subject

endometrial carcinoma

1 reference

Anna V Hoekstra

1

1 reference

20 August 2017

Robert J Kim

2

1 reference

20 August 2017

William Small

3

1 reference

20 August 2017

Alfred W Rademaker

4

1 reference

20 August 2017

Irene B Helenowski

5

1 reference

20 August 2017

Diljeet K Singh

6

1 reference

20 August 2017

Julian C Schink

7

1 reference

20 August 2017

John R Lurain

8

1 reference

20 August 2017

language of work or name

English

0 references

publication date

9 May 2009

1 reference

20 August 2017

1 reference

20 August 2017

volume

114

1 reference

20 August 2017

issue

2

1 reference

20 August 2017

page(s)

273-278

1 reference

20 August 2017

cites work

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.04.013

Adjuvant Brachytherapy Removes Survival Disadvantage of Local Disease Extension in Stage IIIC Endometrial Cancer: A SEER Registry Analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.04.013

Stage IIIC endometrioid corpus cancer includes distinct subgroups

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.04.013

Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.04.013

FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.04.013

Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.04.013

Surgical staging for patients presenting with grade 1 endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.04.013

Complete surgical staging of early endometrial adenocarcinoma: optimizing patient outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.04.013

Para-aortic lymphadenectomy may improve disease-related survival in patients with multipositive pelvic lymph node stage IIIc endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.04.013

Analysis of FIGO Stage IIIc endometrial cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.04.013

The impact of the absolute number and ratio of positive lymph nodes on survival of endometrioid uterine cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.04.013

Stage III endometrial cancer: preoperative predictability, prognostic factors, and treatment outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.04.013

Resection of lymph node metastases influences survival in stage IIIC endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.04.013

Endometrial cancer with para-aortic adenopathy: patterns of failure and opportunities for cure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.04.013

Randomized Phase III Trial of Whole-Abdominal Irradiation Versus Doxorubicin and Cisplatin Chemotherapy in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.04.013

Surgery and postoperative radiation therapy in FIGO Stage IIIC endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.04.013

FIGO stage IIIC endometrial carcinoma: resection of macroscopic nodal disease and other determinants of survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.04.013

Stage III endometrial cancer: analysis of prognostic factors and failure patterns after adjuvant chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.04.013

Pathologic stage III endometrial carcinoma. Prognostic factors and patterns of recurrence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.04.013

Prognostic value of pathologic features and DNA analysis in endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.04.013

Prognostic value of quantitative pathologic features and DNA content in individual patients with stage I endometrial adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.04.013

DNA ploidy in endometrial carcinoma: major objective prognostic factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.04.013

DNA flow cytometric analysis of clinical stage I endometrial carcinomas with lymph node metastases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.04.013

Ovarian metastasis in endometrial carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.04.013

Immunohistochemical profile of endometrial adenocarcinoma: a study of 61 cases and review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.04.013

Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.04.013

A clinical and pathologic study on para-aortic lymph node metastasis in endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.04.013

Treatment of node-positive endometrial cancer with complete node dissection, chemotherapy and radiation therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.04.013

Radiation therapy for surgically proven para-aortic node metastasis in endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.04.013

Adenocarcinoma of the Endometrium: Survival Comparisons of Patients with and without Pelvic Node Sampling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.04.013

Clinical Stage I adenocarcinoma of the endometrium—Analysis of recurrences and the potential benefit of staging lymphadenectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.04.013

Should selective paraaortic lymphadenectomy be part of surgical staging for endometrial cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.04.013

Nodal distribution and its significance in FIGO stage IIIc endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.04.013

10.1016/J.YGYNO.2009.04.013

7 January 2021

Identifiers

DOI

1 reference

20 August 2017

1 reference